Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05181462
Title Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer. (TRIFOUR)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cantargia AB

triple-receptor negative breast cancer


Carboplatin + Gemcitabine

Carboplatin + Gemcitabine + Nidanilimab

Age Groups: senior | adult
Covered Countries ESP

No variant requirements are available.